ITGA1 and cancer: Using different tumor mouse models, Gao et al. [144] reported that the intratumoral TGF-β mediates the conversion of anti-cancer NK cells into intermediate ILC1s (CD49a+CD49b+Eomes+) and ILC1s (CD49a+CD49b−Eomesint).